Details

Autor(en) / Beteiligte

• Orešković, D
• Madero Pohlen, A
• Cvitković, I
• Alen, J F
• Raguž, M
• Álvarez-Sala de la Cuadra, A
• Bazarra Castro, G J
• Bušić, Z
• Konstantinović, I
• Ledenko, V
• Martínez Macho, C
• Müller, D
• Žarak, M
• Jovanov-Milosevic, N
• Chudy, D
• Marinović, T

Titel

Chronic hyperglycemia and intracranial meningiomas

Ist Teil von

• BMC cancer, 2024-04, Vol.24 (1), p.488-488, Article 488

Ort / Verlag

England: BioMed Central Ltd

Erscheinungsjahr

2024

Quelle

MEDLINE

Beschreibungen/Notizen

• Meningiomas are among the most common primary tumors of the central nervous system. Previous research into the meningioma histological appearance, genetic markers, transcriptome and epigenetic landscape has revealed that benign meningiomas significantly differ in their glucose metabolism compared to aggressive lesions. However, a correlation between the systemic glucose metabolism and the metabolism of the tumor hasn't yet been found. We hypothesized that chronic levels of glycaemia (approximated with glycated hemoglobin (HbA1c)) are different in patients with aggressive and benign meningiomas. The study encompassed 71 patients with de novo intracranial meningiomas, operated on in three European hospitals, two in Croatia and one in Spain. Our results show that patients with WHO grade 2 meningiomas had significantly higher HbA1c values compared to patients with grade 1 lesions (P = 0.0290). We also found a significant number of patients (19/71; 26.7%) being hyperglycemic, harboring all the risks that such a condition entails. Finally, we found a significant correlation between our patients' age and their preoperative HbA1c levels (P = 0.0008, ρ(rho) = 0.388), suggesting that older meningioma patients are at a higher risk of having their glycaemia severely dysregulated. These findings are especially important considering the current routine and wide-spread use of corticosteroids as anti-edematous treatment. Further research in this area could lead to better understanding of meningiomas and have immediate clinical impact.